Glucagon

Active ingredient description

Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
H04AA01
Glucagon
H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones
Discover more medicines within H04AA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
GLUCAGEN Powder and solvent for solution for injection
Summary of Product Characteristics (SPC)
UK

Medicines

Glucagon is the active ingredient of these drugs:

Drug
Countries
BAQSIMI

Austria Canada Cyprus Estonia Finland

GLUCAGEN

Australia Austria Brazil Cyprus Finland

GVOKE

United States

OGLUO

Estonia Ireland Lithuania Poland

Chemical formula: C₁₅₃H₂₂₅N₄₃O₄₉S
Molecular mass: 3,482.7 g/mol

3D molecular structure

3D representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 16941-32-5
DrugBank Drug: DB00040
KEGG Drug: D00116
RxNorm Ingredient: 4832
SNOMED-CT Concept: 66603002
Glucagon (substance)
UNII Identifier: 76LA80IG2G
GLUCAGON
 
Next: Usage >